Food and Drug Administration
Center for Drug Evaluation and Research
Nonprescription Drugs Advisory Committee
Holiday Inn –
Call to Order and Opening Remarks Louis R. Cantilena, Jr., M.D., Ph.D.
Conflict of Interest Statement Karen M. Templeton-Somers, Ph.D.
Continued Over-the-Counter (OTC) Status of Ipecac Syrup
Introduction to the Issues Curtis Rosebraugh, M.D., M.P.H.
Deputy Director, Division of Over-the-Counter Drug Products, FDA
Ipecac Syrup: Regulatory History Arlene H. Solbeck, M.S.
Interdisciplinary Scientist, DOTCDP, FDA
Syrup of Ipecac: OTC or not OTC? Milton Tenenbein, M.D.
A Review of Ipecac Syrup Anthony S. Manoguerra, Pharm.D.
Syrup of Ipecac - One Advocate's Perspective William O. Robertson, M.D.
Ipecac Abuse Tomas Jose Silber, M.D.
Questions from the Committee
Open Public Hearing
Questions to the Committee